genomic technologies and computing in healthcare

AboutDr. George Poste serves as Chief Executive Officer of consulting company, Health Technology Networks, which specializes in the application of genomic technologies and computing in healthcare.

HistoryDr. George Poste is the Del E. Webb Professor of Health Innovation and Chief Scientist, The Complex Adaptive Systems Initiative (CASI) (http://www.casi.asu.edu) at Arizona State University (ASU). (March 2009 ASU announces new research initiative, George Poste, director of the Biodesign Institute, will lead the new Complex Adaptive Systems Initiative at ASU). This program integrates research in genomics, synthetic biology and high performance computing to study the altered regulation of molecular networks in human diseases to develop new diagnostic tests for precision (personalized) medicine and the remote monitoring of health status using miniaturized body sensors and mobile devices.

From 2003 to 2009 he directed and built The Biodesign Institute at ASU (www.biodesign.asu.edu/). In leading this Institute, Dr. Poste designed and built 400,000 sq. ft. of new facilities, achieved cumulative research funding of $225 million and recruited over 60 faculty, including three members of the National Academies of Science and Engineering (Biodesign Institute Accomplishments).

He serves on the Board of Directors of Monsanto, Exelixis, Caris Life Sciences, and the Scientific Advisory Boards of the A. Alfred Taubman Medical Research Institute at the University of Michigan, Synthetic Genomics, Human Longevity Inc., Vir Biotechnology and Haplogen GmbH. From 1992 to 1999, he was Chief Science and Technology Officer and President, R&D, of SmithKline Beecham (SB). During his tenure at SB, he was associated with the successful registration of multiple drug, vaccine and diagnostic products. He was named “R&D Scientist of the Year” byR&D Magazine (2004), he received the Einstein award from the Global Business Leadership Council (2006), the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry (2009), and the Lifetime Achievement award from the Arizona BioIndustry Association (2016).

He was named “R&D Scientist of the Year” byR&D Magazine (2004), he received the Einstein award from the Global Business Leadership Council (2006), the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry (2009), and the Lifetime Achievement award from the Arizona BioIndustry Association (2016).

He is a Fellow of the U.K. Royal Society, the Royal College of Pathologists and the U.K. Academy of Medicine, a member of the Council for Foreign Relations and the US Academy of Medicine Global Forum on Infectious Disease, a former Distinguished Fellow at the Hoover Institution at Stanford University and a Governor of the Bulletin of Atomic Scientists. He has served as a member of the Defense Science Board of the U.S. Department of Defense and currently serves on advisory committees for several U.S. government agencies in defense, intelligence, national security, and healthcare.

His personal interests are in automobile racing, military history, photography and exploring the deserts of the American Southwest.